Apellis Pharmaceuticals
APLS
APLS
133 hedge funds and large institutions have $1.34B invested in Apellis Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 50 increasing their positions, 37 reducing their positions, and 24 closing their positions.
Holders
133
Holders Change
+4
Holders Change %
+3.1%
% of All Funds
2.63%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
33
Increased
50
Reduced
37
Closed
24
Calls
$43.1M
Puts
$36M
Net Calls
+$7.01M
Net Calls Change
-$1.55M
Top Buyers
Top Sellers
1 |
1
Millennium Management
New York
|
$17.8M |
2 |
SAM
2
Sectoral Asset Management
Montreal,
Quebec, Canada
|
$13.9M |
3 |
O
3
OrbiMed
New York
|
$0 |
4 |
![]()
4
Adage Capital Partners
Boston,
Massachusetts
|
$3.06M |
5 |
5
Morgan Stanley
New York
|
$3.75M |